HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oculogyric crises induced by levodopa in PLA2G6 parkinsonism-dystonia.

AuthorsTuhin Virmani, Mary Ann Thenganatt, Jill S Goldman, Christian Kubisch, Paul E Greene, Roy N Alcalay
JournalParkinsonism & related disorders (Parkinsonism Relat Disord) Vol. 20 Issue 2 Pg. 245-7 (Feb 2014) ISSN: 1873-5126 [Electronic] England
PMID24182522 (Publication Type: Case Reports, Letter, Research Support, Non-U.S. Gov't, Video-Audio Media)
Chemical References
  • Antiparkinson Agents
  • Levodopa
  • Group VI Phospholipases A2
  • PLA2G6 protein, human
Topics
  • Adolescent
  • Adult
  • Age of Onset
  • Antiparkinson Agents (adverse effects)
  • Dystonic Disorders (drug therapy, genetics, pathology)
  • Female
  • Group VI Phospholipases A2 (genetics)
  • Humans
  • Levodopa (adverse effects)
  • Male
  • Ocular Motility Disorders (chemically induced)
  • Parkinson Disease (drug therapy, genetics, pathology)
  • Siblings
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: